Lymphocytic Leukemia, Chronic News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Loophole in chronic lymphocytic leukemia treatment - Science Daily



Loophole in chronic lymphocytic leukemia treatment 
Science Daily
A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients. The study, which will be published January 4 in the Journal of ...

 


With So Many Options for CLL, the Best Treatment May Be a Clinical Trial - Medscape



Medscape
 
With So Many Options for CLL, the Best Treatment May Be a Clinical Trial 
Medscape
The treatment strategies for chronic lymphocytic leukemia (CLL) are evolving so quickly that the best option for many patients?perhaps most patients?is not the latest therapy to show an advantage over a previous standard, but enrollment in a clinical ...

 


Study reveals a loophole in treatment of chronic lymphocytic leukemia - News-Medical.net



News-Medical.net
 
Study reveals a loophole in treatment of chronic lymphocytic leukemia 
News-Medical.net
A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients. The study, which will be published January 4 in the Journal of ...

and more » 


BGNE Up, Up And Away, Data Vindicates CGEN's Strategy, JNCE Awaits ICONIC Data - Nasdaq



BGNE Up, Up And Away, Data Vindicates CGEN's Strategy, JNCE Awaits ICONIC Data 
Nasdaq
A pivotal phase II trial in China of BGB-3111 in relapsed/refractory mantle cell lymphoma; a global phase III trial of BGB-3111 compared to bendamustine and rituximab in treatment-naïve chronic lymphocytic leukemia / small lymphocytic lymphoma ...

and more » 


Venetoclax Demonstrates Strong Activity in CLL After BCR Inhibitor - OncLive



OncLive
 
Venetoclax Demonstrates Strong Activity in CLL After BCR Inhibitor 
OncLive
?Data for ibrutinib resistance mutations show the potential for venetoclax to eradicate ibrutinib-resistant clones?a finding that has not previously been reported in the context of a prospective clinical trial and represents an important advance in ...

and more » 


United States B-Cell Chronic Lymphocytic Leukemia Treatment Market: Key vendors, Quality, Reliability And ... - Carelton Free Press



United States B-Cell Chronic Lymphocytic Leukemia Treatment Market: Key vendors, Quality, Reliability And ... 
Carelton Free Press
Questale published a new industry research that focuses on United States B-Cell Chronic Lymphocytic Leukemia Treatment market and delivers in-depth market analysis and future prospects of United States B-Cell Chronic Lymphocytic Leukemia Treatment ...

 


Venetoclax for Older Patients With AML? 'Remarkable' Response - Medscape



Medscape
 
Venetoclax for Older Patients With AML? 'Remarkable' Response 
Medscape
Less than 30% of patients achieve a clinical response, median survival is less than 1 year, and neither drug is curative, they point out. This phase 1b study provides hope for patients who need one. While venetoclax has changed the treatment landscape ...

 


Monitoring for AML Remissions: Are We Measuring Properly? - Curetoday.com



Curetoday.com
 
Monitoring for AML Remissions: Are We Measuring Properly? 
Curetoday.com
The monitoring of MRD is currently used frequently in myeloma and chronic lymphocytic leukemia, and is beginning to show progress in acute lymphoblastic leukemia. Stone is hopeful that one day, MRD will play as key a role in AML as it does with other ...

and more » 


Novel Biomaterials Boost T-Cell Production - Genetic Engineering & Biotechnology News



Genetic Engineering & Biotechnology News
 
Novel Biomaterials Boost T-Cell Production 
Genetic Engineering & Biotechnology News
?This platform also rescues expansion of T cells isolated from CLL [chronic lymphocytic leukemia] patients, which often show limited responsiveness and other features resembling exhaustion. By simplifying the process of cell expansion and improving T ...

and more » 


Researchers Detect a Loophole in Chronic Lymphocytic Leukemia Treatment - Newswise (press release)



Researchers Detect a Loophole in Chronic Lymphocytic Leukemia Treatment 
Newswise (press release)
... that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients. The study, which will be published January 4 in the Journal of Experimental Medicine, reveals that ibrutinib has a diminished ...

and more »